Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgAN - IgA Nephropathy”

241 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 241 results

Not applicableStudy completedNCT01838239
What this trial is testing

Development of a Metabolic Assessment Tool for Chronic Kidney Disease

Who this might be right for
Immunoglobulin A NephropathyHealthy Subjects
University of California, Davis 12
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Post-approval studies (Phase 4)Study completedNCT00367562
What this trial is testing

Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

Who this might be right for
IGA Nephropathy
Hospital Britanico 20
Large-scale testing (Phase 3)Study completedNCT00549692
What this trial is testing

Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Kuhnil Pharmaceutical Co., Ltd. 152
Large-scale testing (Phase 3)Looking for participantsNCT06935357
What this trial is testing

Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Biogen 454
Testing effectiveness (Phase 2)Active Not RecruitingNCT04663204
What this trial is testing

The Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A NephropathyKidney DiseasesGlomerulonephritis, IGA+3 more
University of Leicester 12
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Early research (Phase 1)Looking for participantsNCT05942625
What this trial is testing

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

Who this might be right for
IgA NephropathyFocal Segmental Glomerulosclerosis
Hansoh BioMedical R&D Company 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06635772
What this trial is testing

The Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Who this might be right for
Immunoglobulin a Nephropathy
Hansoh BioMedical R&D Company 90
Not applicableStudy completedNCT05200871
What this trial is testing

Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

Who this might be right for
Focal Segmental GlomerulosclerosisImmunoglobulin A Nephropathy
Travere Therapeutics, Inc. 487
Not applicableUnknownNCT02829164
What this trial is testing

Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region

Who this might be right for
Tonsillectomy
University Hospital, Strasbourg, France 20
Not applicableTemporarily pausedNCT02471599
What this trial is testing

Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 100
Early research (Phase 1)Study completedNCT06490991
What this trial is testing

Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria，IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 16
Not applicableUnknownNCT04438603
What this trial is testing

The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 180
Not applicableLooking for participantsNCT06654596
What this trial is testing

Efficacy and Safety of Telitacicept in IgAN

Who this might be right for
IgA Nephropathy (IgAN)Kidney DiseasesTelitacicept+1 more
Ruijin Hospital 118
Testing effectiveness (Phase 2)Study completedNCT05065970
What this trial is testing

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Who this might be right for
Immunoglobulin A (IgA) Nephropathy
HI-Bio, A Biogen Company 54
Not applicableStudy completedNCT02529722
What this trial is testing

Biomarkers for the Progression of IgA Nephropathy

Who this might be right for
IgA NephropathyGlomerular Diseases
Istanbul University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04716231
What this trial is testing

Atacicept in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyBerger Disease
Vera Therapeutics, Inc. 376
Not applicableUnknownNCT01781312
What this trial is testing

Probiotics in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Uppsala University Hospital 20
Early research (Phase 1)Looking for participantsNCT07248865
What this trial is testing

CLYM116 in Normal Healthy Volunteers

Who this might be right for
Healthy Volunteers
Climb Bio, Inc. 48
Load More Results